Clinical predictive value of FT4/FT3 ratio for the risk of all-cause death in hospital in acute myocardial infarction patients
CSTR:
Author:
Affiliation:

1.Department of Cardiology of the Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116023, China;2.Department of Cardiology, the First Affiliated Hospital of Air Force Military Medical University, Xi'an, Shaanxi 710032, China;3.Heze Medical College, Heze, Shandong 274000, China)

Clc Number:

R5

  • Article
  • | |
  • Metrics
  • |
  • Reference [28]
  • |
  • Related [20]
  • | | |
  • Comments
    Abstract:

    Aim To investigate the clinical predictive value of free thyroid hormone (FT4)/free triiodothyronine (FT3) ratio for the risk of all-cause death in hospital in acute myocardial infarction (AMI) patients. Methods The clinical data of AMI patients who underwent coronary angiography or percutaneous coronary intervention (PCI) in the Department of Cardiology of the Second Affiliated Hospital of Dalian Medical University from January 2016 to December 2022 were collected retrospectively, a total of 63 patients with complete medical history and died during hospitalization were selected, 180 AMI patients who did not die during hospitalization in the same period were selected as the control group. Results Age, ST elevation myocardial infarction (STEMI), renal insufficiency, atrial fibrillation, heart rate, KillipⅢ/Ⅳ, multi-vessel disease, cardiac troponin I and brain natriuretic peptide (BNP) in the in-hospital death group were higher than those in the survival group, while ejection fraction (EF) was lower than that in the survival group, the difference was statistically significant (P<0.05). FT4 and FT4/FT3 ratio in the in-hospital death group was higher than those in the survival group, and the FT3 was lower than that in the survival group, the difference was statistically significant (P<0.05). Multivariate Logistic regression analysis showed that the FT4/FT3 ratio was associated with the risk of all-cause death in hospital in AMI patients (OR=1.4,5% CI:1.193~2.850, P<0. 05). In addition, age, heart rate, KillipⅢ/Ⅳ grade, STEMI, renal insufficiency and low EF were also positively correlated with the risk of all-cause death in hospital in AMI patients (OR=1.4,1.1,2.7,2.8,4.5,4.407, P<0.05). The results of the ROC curve analysis showed that the FT4/FT3 ratio (AUC=0.4,5%CI:0.708~0.839, P<0.001) predicted the risk of all-death in hospital better than FT4 (AUC=0.0,5%CI:0.561~0.719, P=0.001) or FT3 (AUC=0.9,5%CI:0.647~0.790, P<0.001) alone. The difference in area under the ROC curve was statistically significant (P=0.001 and P=0.042). Conclusions FT4/FT3 ratio is related to the risk of all-cause death in hospital in AMI patients, which can predict the risk of all-cause death in hospital in AMI patients. Compared with FT3 or FT4 alone, FT4/FT3 ratio has better clinical predictive value for all-cause death in hospital in AMI patients.

    Reference
    [1] 马丽媛, 王增武, 樊静, 等.《中国心血管健康与疾病报告2022》要点解读.中国全科医学, 3,6(32):3975-3994.MA L Y, WANG Z W, FAN J, et al.Interpretation of report on cardiovascular health and diseases in China 2022.Chin Gen Pract, 3,6(32):3975-3994.
    [2] XU H, YANG Y, WANG C, et al.Association of hospital-level differences in care with outcomes among patients with acute ST-segment elevation myocardial infarction in China.JAMA Netw Open, 0,3(10):e2021677.
    [3] COLLET J P, THIELE H, BARBATO E, et al.2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.Eur Heart J, 1,2(14):1289-1367.
    [4] IBANEZ B, JAMES S, AGEWALL S, et al.2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation:The Task Force for the Management of Acute Myocardial Infarction in Patients Presenting with ST-segment Elevation of the European Society of Cardiology (ESC).Eur Heart J, 8,9(2):119-177.
    [5] 杨云潇, 张铭.甲状腺功能减退症与动脉粥样硬化的研究新进展.中国动脉硬化杂志, 1,9(6):489-493.YANG Y X, ZHANG M.Research progress of hypothyroidism and atherosclerosis.Chin J Arterioscler, 1,9(6):489-493.
    [6] JABBAR A, PINGITORE A, PEARCE S H, et al.Thyroid hormones and cardiovascular disease.Nat Rev Cardiol, 7,4(1):39-55.
    [7] ATAOGLU H E, AHBAB S, SEREZ M K, et al.Prognostic significance of high free T4 and low free T3 levels in non-thyroidal illness syndrome.Eur J Intern Med, 8,7:91-95.
    [8] MERKE A, MERKE J, SILBERNAGEL G, et al.Free thyroid hormones and mortality in Caucasians undergoing angiography:the Ludwigshafen risk and cardiovascular health (LURIC) study.Endocr Pract, 7,3(3):288-298.
    [9] MAIA A L, GOEMANN I M, MEYER E L, et al.Deiodinases:the balance of thyroid hormone:type 1 iodothyronine deiodinase in human physiology and disease.J Endocrinol, 1,9(3):283-297.
    [10] LANG X, LI Y, ZHANG D, et al.FT3/FT4 ratio is correlated with all-cause mortality, cardiovascular mortality, and cardiovascular disease risk:NHANES 2007-2012.Front Endocrinol (Lausanne), 2,3:964822.
    [11] YUAN D, ZHANG C, JIA S, et al.Predictive value of free triiodothyronine (FT3) to free thyroxine (FT4) ratio in long-term outcomes of euthyroid patients with three-vessel coronary artery disease.Nutr Metab Cardiovasc Dis, 1,1(2):579-586.
    [12] THYGESEN K, ALPERT J S, JAFFE A S, et al.Fourth universal definition of myocardial infarction (2018).J Am Coll Cardiol, 8,2(18):2231-2264.
    [13] WILLIAMS B, MANCIA G, SPIERING W, et al.2018 ESC/ESH guidelines for the management of arterial hypertension.Eur Heart J, 8,9(33):3021-3104.
    [14] ELSAYED N A, ALEPPO G, ARODA V R, et al.7.Diabetes technology:standards of care in diabetes-2023.Diabetes Care, 3,6(Suppl 1):S111-S127.
    [15] 骆景光, 杨明, 韩凌, 等.吸烟对高血压患者血压变异性的影响.中华高血压杂志, 3,1(2):178-180.LUO J G, YANG M, HAN L, et al.Effect of smoking on blood pressure variability in hypertensive patients.Chin J Hypertens, 3,1(2):178-180.
    [16] GRAIS I M, SOWERS J R.Thyroid and the heart.Am J Med, 4,7(8):691-698.
    [17] RAZVI S, JABBAR A, PINGITORE A, et al.Thyroid hormones and cardiovascular function and diseases.J Am Coll Cardiol, 8,1(16):1781-1796.
    [18] BAUMGARTNER C, DA C B, COLLET T H, et al.Thyroid function within the normal range, subclinical hypothyroidism, and the risk of atrial fibrillation.Circulation, 7,6(22):2100-2116.
    [19] CAPPOLA A R, ARNOLD A M, WULCZYN K, et al.Thyroid function in the euthyroid range and adverse outcomes in older adults.J Clin Endocrinol Metab, 5,0(3):1088-1096.
    [20] CHAKER L, VAN DEN BERG M E, NIEMEIJER M N, et al.Thyroid function and sudden cardiac death:a prospective population-based cohort study.Circulation, 6,4(10):713-722.
    [21] ZHANG H, CHE W, SHI K, et al.FT4/FT3 ratio:a novel biomarker predicts coronary microvascular dysfunction (CMD) in euthyroid INOCA patients.Front Endocrinol (Lausanne), 2,3:1021326.
    [22] PASQUALETTI G, CALSOLARO V, BERNARDINI S, et al.Degree of peripheral thyroxin deiodination, frailty, and long-term survival in hospitalized older patients.J Clin Endocrinol Metab, 8,3(5):1867-1876.
    [23] LI L, GUO C Y, YANG J, et al.Negative association between free triiodothyronine level and international normalized ratio in euthyroid subjects with acute myocardial infarction.Acta Pharmacol Sin, 1,2(11):1351-1356.
    [24] KHAN M, MUKHERJEE S, BANK S, et al.Role of thyroid hormone and oxidant stress in cardiovascular diseases.Endocr Metab Immune Disord Drug Targets, 1,1(7):1282-1288.
    [25] MANCINI A, Di SEGNI C, RAIMONDO S, et al.Thyroid hormones, oxidative stress, and inflammation.Mediators Inflamm, 6,6:6757154.
    [26] LIU Y, MA M, LI L, et al.Association between sensitivity to thyroid hormones and dyslipidemia in patients with coronary heart disease.Endocrine, 3,9(3):459-468.
    [27] GU Y, LI H, BAO X, et al.The relationship between thyroid function and the prevalence of type 2 diabetes mellitus in euthyroid subjects.J Clin Endocrinol Metab, 7,2(2):434-442.
    [28] FARASAT T, CHEEMA A M, KHAN M N.Hyperinsulinemia and insulin resistance is associated with low T3/T4 ratio in pre diabetic euthyroid Pakistani subjects.J Diabetes Complications, 2,6(6):522-525.
    Cited by
Get Citation

XU Qing, GUO Chunmian, WU Qingjie, CHEN Yan, HAN Yuanyuan, JU Haonan, ZHAN Xin. Clinical predictive value of FT4/FT3 ratio for the risk of all-cause death in hospital in acute myocardial infarction patients[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2023,31(12):1037-1042.

Copy
Share
Article Metrics
  • Abstract:241
  • PDF: 619
  • HTML: 0
  • Cited by: 0
History
  • Received:September 16,2023
  • Revised:October 10,2023
  • Online: December 29,2023
Article QR Code